Your browser doesn't support javascript.
loading
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
Gangat, Naseema; Guglielmelli, Paola; Szuber, Natasha; Begna, Kebede H; Patnaik, Mrinal M; Litzow, Mark R; Al-Kali, Aref; Foran, James M; Palmer, Jeanne M; Alkhateeb, Hassan; Elliott, Michelle A; Hanson, Curtis A; Pardanani, Animesh; Mannelli, Francesco; Vannucchi, Alessandro M; Tefferi, Ayalew.
Afiliação
  • Gangat N; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Szuber N; Department of Hematology, Université de Montréal, Quebec, Canada.
  • Begna KH; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Litzow MR; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Foran JM; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Palmer JM; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Alkhateeb H; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Elliott MA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hanson CA; Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Pardanani A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Mannelli F; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Tefferi A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 96(7): 781-789, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33844862

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azacitidina / Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Compostos Bicíclicos Heterocíclicos com Pontes / Decitabina / Transtornos Mieloproliferativos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Azacitidina / Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Compostos Bicíclicos Heterocíclicos com Pontes / Decitabina / Transtornos Mieloproliferativos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos